
Sign up to save your podcasts
Or


Drug company Merck is applying for emergency use authorization in the U.S. for a new oral treatment for COVID-19 that trials suggest cuts the risk of hospitalization or death by half. We'll talk with UCSF's Dr. Monica Gandhi about the promising new treatment, get the latest coronavirus numbers for the Bay Area, and hear what to expect now that flu season is around the corner.
Learn more about your ad choices. Visit megaphone.fm/adchoices
By KQED4.3
695695 ratings
Drug company Merck is applying for emergency use authorization in the U.S. for a new oral treatment for COVID-19 that trials suggest cuts the risk of hospitalization or death by half. We'll talk with UCSF's Dr. Monica Gandhi about the promising new treatment, get the latest coronavirus numbers for the Bay Area, and hear what to expect now that flu season is around the corner.
Learn more about your ad choices. Visit megaphone.fm/adchoices

38,430 Listeners

6,881 Listeners

9,238 Listeners

4,022 Listeners

393 Listeners

114 Listeners

247 Listeners

6,467 Listeners

1,065 Listeners

4,696 Listeners

85 Listeners

2,380 Listeners

187 Listeners

434 Listeners

131 Listeners

395 Listeners

16,512 Listeners

31 Listeners

16,525 Listeners

11,013 Listeners

1,600 Listeners